Page last updated: 2024-10-21

n-methyl-3,4-methylenedioxyamphetamine and Abdominal Migraine

n-methyl-3,4-methylenedioxyamphetamine has been researched along with Abdominal Migraine in 4 studies

N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Seetohul, LN1
Pounder, DJ1
Bhattacharyya, S1
Schapira, AH1
Mikhailidis, DP1
Davar, J1
Trittibach, P1
Frueh, BE1
Goldblum, D1
Whitaker-Azmitia, PM1

Reviews

1 review available for n-methyl-3,4-methylenedioxyamphetamine and Abdominal Migraine

ArticleYear
Drug-induced fibrotic valvular heart disease.
    Lancet (London, England), 2009, Aug-15, Volume: 374, Issue:9689

    Topics: Antiparkinson Agents; Appetite Depressants; Cabergoline; Dexfenfluramine; Dopamine Agonists; Drug Mo

2009

Other Studies

3 other studies available for n-methyl-3,4-methylenedioxyamphetamine and Abdominal Migraine

ArticleYear
Four fatalities involving 5-IT.
    Journal of analytical toxicology, 2013, Volume: 37, Issue:7

    Topics: Alcohol Drinking; Autopsy; Chromatography, High Pressure Liquid; Designer Drugs; Female; Forensic To

2013
Bilateral angle-closure glaucoma after combined consumption of "ecstasy" and marijuana.
    The American journal of emergency medicine, 2005, Volume: 23, Issue:6

    Topics: Adult; Cannabis; Emergency Medicine; Female; Glaucoma, Angle-Closure; Gonioscopy; Humans; Illicit Dr

2005
Depression to ecstasy. The Neuropharmacology of Serotonin sponsored by the New York Academy of Sciences, New York, NY, USA, July 10-13, 1989.
    The New biologist, 1989, Volume: 1, Issue:2

    Topics: 3,4-Methylenedioxyamphetamine; Animals; Brain Mapping; Depression; Humans; Mental Disorders; Migrain

1989